Salicylaldehyde derivatives as new protein kinase CK2 inhibitors

Biochimica et Biophysica Acta - General Subjects

Volumn 1780, Issue 12, 2008, Pages 1412-1420

  Prudent, Renaud ^a,b,c   López Ramos, Miriam ^d,e,f   Moucadel, Virginie ^a,b,c   Barette, Caroline ^b   Grierson, David ^d,e   Mouawad, Liliane ^d,f   Florent, Jean Claude ^d,e   Lafanechère, Laurence ^b   Schmidt, Frédéric ^d,e   Cochet, Claude ^a,b,c  

^a INSERM   (France)

^b CEA GRENOBLE   (France)

^c UNIV GRENOBLE ALPES   (France)

^d INSTITUT CURIE   (France)

^e CNRS   (France)

^f Centre Universitaire   (France)

Author keywords

Docking; Inhibitor; Molecular modeling; Protein kinase CK2; Salicylaldehyde

Indexed keywords

1 FORMYL 6 FORMYLOXY 2 HYDROXYANTHRACENE; 5 BROMO 1 FORMYL 6 METHOXY 2 NAPHTHOL; ALDEHYDE DERIVATIVE; ANTHRACENE SALICYLALDEHYDE DERIVATIVE; CASEIN KINASE II; NAPHTHOSALICYLADEHYDE DERIVATIVE; PROTEIN KINASE INHIBITOR; SALICYLALDEHYDE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; AUTOANALYSIS; BIOLOGICAL ACTIVITY; CELL VIABILITY; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; SIMULATION; STRUCTURE ACTIVITY RELATION;

EID: 53149113750     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2008.06.010     Document Type: Article

References (33)

1. Ahmed K., Gerber D.A., and Cochet C. Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol. 12 (2002) 226-230
2. Laramas M., Pasquier D., Filhol O., Ringeisen F., Descotes J.L., and Cochet C. Nuclear localization of protein kinase CK2 catalytic subunit (CK2alpha) is associated with poor prognostic factors in human prostate cancer. Eur. J. Cancer. 43 (2007) 928-934
3. O-charoenrat P., Rusch V., Talbot S.G., Sarkaria I., Viale A., Socci N., Ngai I., Rao P., and Singh B. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung. Clin. Cancer Res. 10 (2004) 5792-5803
4. Kim J.S., Eom J.I., Cheong J.W., Choi A.J., Lee J.K., Yang W.I., and Min Y.H. Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia. Clin. Cancer Res. 13 (2007) 1019-1028
5. Wang G., Unger G., Ahmad K.A., Slaton J.W., and Ahmed K. Downregulation of CK2 induces apoptosis in cancer cells-a potential approach to cancer therapy. Mol. Cell. Biochem. 274 (2005) 77-84
6. Unger G.M., Davis A.T., Slaton J.W., and Ahmed K. Protein kinase CK2 as regulator of cell survival: implications for cancer therapy. Curr. Cancer Drug Targets 4 (2004) 77-84
7. Fabbro D., Ruetz S., Buchdunger E., Cowan-Jacob S.W., Fendrich G., Liebetanz J., Mestan J., O'Reilly T., Traxler P., Chaudhuri B., Fretz H., Zimmermann J., Meyer T., Caravatti G., Furet P., and Manley P.W. Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacol. Ther. 93 (2002) 79-98
8. Seeber S., Issinger O.G., Holm T., Kristensen L.P., and Guerra B. Validation of protein kinase CK2 as oncological target. Apoptosis 10 (2005) 875-885
9. Slaton J.W., Unger G.M., Sloper D.T., Davis A.T., and Ahmed K. Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model. Mol. Cancer Res. 2 (2004) 712-721
10. Meggio F., and Pinna L.A. One-thousand-and-one substrates of protein kinase CK2?. FASEB J. 17 (2003) 349-368
11. Cohen P. Protein kinases-the major drug targets of the twenty-first century?. Nat. Rev. Drug Discov. 1 (2002) 309-315
12. Sarno S., Moro S., Meggio F., Zagotto G., Dal Ben D., Ghisellini P., Battistutta R., Zanotti G., and Pinna L.A. Toward the rational design of protein kinase casein kinase-2 inhibitors. Pharmacol. Ther. 93 (2002) 159-168
13. Sarno S., Salvi M., Battistutta R., Zanotti G., and Pinna L.A. Features and potentials of ATP-site directed CK2 inhibitors. Biochim. Biophys. Acta 1754 (2005) 263-270
14. Sarno S., Ruzzene M., Frascella P., Pagano M.A., Meggio F., Zambon A., Mazzorana M., Di Maira G., Lucchini V., and Pinna L.A. Development and exploitation of CK2 inhibitors. Mol. Cell. Biochem. 274 (2005) 69-76
15. Chilin A., Battistutta R., Bortolato A., Cozza G., Zanatta S., Poletto G., Mazzorana M., Zagotto G., Uriarte E., Guiotto A., Pinna L.A., Meggio F., and Moro S. J. Med. Chem. 51 (2008) 752-759
16. Golub A.G., Yakovenko O.Y., Bdzhola V.G., Sapelkin V.M., Zien P., and Yarmoluk S.M. Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2. J. Med. Chem. 49 (2006) 6443-6450
17. Sarno S., De Moliner E., Ruzzene M., Pagano M.A., Battistutta R., Bain J., Fabbro D., Schoepfer J., Elliott M., Furet P., Meggio F., Zanotti G., and Pinna L.A. Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA). Biochem. J. 374 Part 3 (2003) 639-646
18. Pagano M.A., Poletto G., Di Maira G., Cozza G., Ruzzene M., Sarno S., Bain J., Elliott M., Moro S., Zagotto G., Meggio F., and Pinna L.A. Tetrabromocinnamic Acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors. ChemBioChem 8 (2006) 129-139
19. Battistutta R., De Moliner E., Sarno S., Zanotti G., and Pinna L.A. Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole. Protein Sci. 10 (2001) 2200-2206
20. Battistutta R., Mazzorana M., Sarno S., Kazimierczuk Z., Zanotti G., and Pinna L.A. Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole. Chem Biol. 12 (2005) 1211-1219
21. Nie Z., Perretta C., Erickson P., Margosiak S., Almassy R., Lu J., Averill A., Yager K.M., and Chu S. Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2. Bioorg. Med. Chem Lett. 17 (2007) 4191-4195
22. Filhol O., Cochet C., Wedegaertner P., Gill G.N., and Chambaz E.M. Coexpression of both alpha and beta subunits is required for assembly of regulated casein kinase II. Biochemistry 30 (1991) 11133-11140
23. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., and Bourne P.E. The protein data bank. Nucleic Acids Res. 28 (2000) 235-242
24. FlexX, version 1.13.5; Sankt Augustin, Germany BioSolveIT GmbH. Rarey M., Kramer B., Lengauer T., and Klebe G. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 261 (1996) 470-489
25. SYBYL, version 6.9; Tripos Inc. (1699 South Hanley Road, St. Louis, MO, 63144)
26. Heriche J.K., Lebrin F., Rabilloud T., Leroy D., Chambaz E.M., and Goldberg Y. Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha. Science 276 (1997) 952-955
27. Buisson J.-P., Royer R., Gayral P., Fourniat J., Bilger C., and Demerseman P. Synthèse et essais exploratoires contre les bactéries et les protozoaires de dérivés polyméthoxylés du nitro-2 naphto[2,1-b]furanne. Eur. J. Med. Chem., 22 (1987) 213-219
28. Niefind K., Guerra B., Ermakova I., and Issinger O.-G. Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme. EMBO J., 20 (2001) 5305-5311
29. Bongini A., Panunzio M., Bandini E., Campana E., Martelli G., and Spunta G. Synthesis of perhydroxazin-4-ones. Competitive Mukaiyama versus hetero Diels-Alder reaction in the cycloaddition of 2-aza-3-trimethylsilyloxy-1,3-butadiene and aldehydes. Tetrahedron: Asymmetry 12 (2001) 439-454
30. Kupchan S.M., and Wormser H.C. Tumor Inhibitors. X.1 Photochemical synthesis of phenanthrenes. Synthesis of aristolochic acid and related compounds 2-4. J. Org. Chem. 30 (1965) 3792-3800
31. Reetz M.T., Kyung S.H., and Hullmann M. CH3Li/TiCl4: a non-basic and highly selective grignard analogue. Tetrahedron 42 (1986) 2931-2935
32. Patel V.F., Andis S.L., Enkema J.K., Johnson D.A., Kennedy J.H., Mohamadi F., Schultz R.M., Soose D.J., and Spees M.M. Total synthesis of seco (+)- and ent-(-)-oxaduocarmycin SA: construction of the (chloromethyl)indoline alkylating subunit by a novel intramolecular aryl radical cyclization onto a vinyl chloride. J. Org. Chem. 62 (1997) 8868-8874
33. Humphrey W., Dalke A., and Schulten K. VMD - visual molecular dynamics. J. Molec. Graphics 14 (1996) 33-38